Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.

BJU international - 1 May 2014

Chang Bao-Li, Hughes Lucinda, Chen David Y T, Gross Laura, Ruth Karen, Giri Veda N

Abstract excerpt

OBJECTIVE: To validate six previously identified markers among men at increased risk of prostate cancer (African-American men and those with a family history of prostate cancer) enrolled in the Prostate Cancer Risk Assessment Program (PRAP), a prostate cancer screening study. PATIENTS AND METHODS: Eligibility criteria for PRAP include age 35-69 years with a family history of prostate cancer, African-American...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Risk Assessment

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 23937305
DOI: 10.1111/bju.12264
PMCID: PMC3830710

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.PMID 23937305Read ↗

Genetic correction of PSA values using sequence variants associated with PSA levels.Semantic proximity Read ↗

A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.Semantic proximity Read ↗

Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population.Semantic proximity Read ↗

Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk.Semantic proximity Read ↗

Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination.Semantic proximity Read ↗

8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort.Semantic proximity Read ↗

Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.Semantic proximity Read ↗

A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease.Semantic proximity Read ↗

Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.Semantic proximity Read ↗

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.Semantic proximity Read ↗

Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.Semantic proximity Read ↗

Genetic variants and family history predict prostate cancer similar to prostate-specific antigen.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.